NanoViricides, Inc.
NNVC · AMEX
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $6 | $5 | $6 | $6 |
| G&A Expenses | $4 | $3 | $3 | $2 |
| SG&A Expenses | $4 | $3 | $3 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $10 | $9 | $9 | $8 |
| Operating Income | -$10 | -$9 | -$9 | -$8 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$9 | -$8 | -$9 | -$8 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$9 | -$8 | -$9 | -$8 |
| % Margin | – | – | – | – |
| EPS | -0.63 | -0.7 | -0.74 | -0.7 |
| % Growth | 10% | 5.4% | -5.7% | – |
| EPS Diluted | -0.63 | -0.7 | -0.74 | -0.7 |
| Weighted Avg Shares Out | 15 | 12 | 12 | 12 |
| Weighted Avg Shares Out Dil | 15 | 12 | 12 | 12 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$9 | -$7 | -$8 | -$7 |
| % Margin | – | – | – | – |